These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2747741)

  • 1. Skin blister fluid levels of ketoconazole during repetitive administration in healthy man.
    Korting HC; Lukacs A; Schäfer-Korting M; Heykants J; Behrendt H
    Mycoses; 1989 Jan; 32(1):39-45. PubMed ID: 2747741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
    Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil.
    Korting HC; Schäfer-Korting M; Kees F; Lukacs A; Grobecker H
    Eur J Clin Pharmacol; 1990; 39(1):33-6. PubMed ID: 2276386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(3):351-4. PubMed ID: 4076331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
    Warlich R; Korting HC; Schäfer-Korting M; Mutschler E
    Antimicrob Agents Chemother; 1990 Jan; 34(1):78-81. PubMed ID: 2327762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of griseofulvin in blood and skin suction blister fluid of rats.
    Schäfer-Korting M
    Drug Metab Dispos; 1987; 15(3):374-6. PubMed ID: 2886314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermo-epidermal distribution of ketoconazole in man.
    Ortonne JP; Levron JC; Stephan P
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):540-3. PubMed ID: 3243657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response.
    Schäfer-Korting M; Belz GG; Brauer J; Alken RG; Mutschler E
    Clin Pharmacol Ther; 1987 Dec; 42(6):613-20. PubMed ID: 3690939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg).
    Vaillant L; Machet L; Taburet AM; Sorensen H; Lorette G
    Br J Dermatol; 1992 Jun; 126(6):591-5. PubMed ID: 1610710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin blister fluid--an access to the peripheral compartment. Implications of a study on the behaviour of bendroflumethiazide in rats.
    Schäfer-Korting M
    Arzneimittelforschung; 1985; 35(12):1828-31. PubMed ID: 4096738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically.
    Meinardi MM; Van Eendenburg JP; Oosting J; Van Boxtel CJ; De Rie MA; Bos JD
    Br J Dermatol; 1990 May; 122(5):671-6. PubMed ID: 2354118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.
    Vaillant L; Lorette G; Loulergue J; Audurier A
    Eur J Clin Pharmacol; 1987; 33(5):529-30. PubMed ID: 3501376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
    Schempp CM; Winghofer B; Langheinrich M; Schöpf E; Simon JC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):299-304. PubMed ID: 10461100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
    Fetterly GJ; Ong CM; Bhavnani SM; Loutit JS; Porter SB; Morello LG; Ambrose PG; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):148-52. PubMed ID: 15616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and skin blister fluid concentrations of trimethoprim following its oral administration.
    Klimowicz A; Nowak A; Kadyków M
    Eur J Clin Pharmacol; 1988; 34(4):377-80. PubMed ID: 3402523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.